DHFR and breast cancer: On conclusion, two of the herein considered gold compounds confirm their strong anticancer activities in vitro on the regards of aggressive BC subtypes cells through multitarget mechanisms: it was assessed their action through the inhibition of both TrxR and DHFR enzymes and their binding to transporter proteins as BSA and ATF, that in vivo raised much attention for their possible involvement in the mechanism of action.